These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1378074)
1. Two major groups of neutralizing anti-gp120 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site. Chamat S; Nara P; Berquist L; Whalley A; Morrow WJ; Köhler H; Kang CY J Immunol; 1992 Jul; 149(2):649-54. PubMed ID: 1378074 [TBL] [Abstract][Full Text] [Related]
2. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120. Kang CY; Hariharan K; Posner MR; Nara P J Immunol; 1993 Jul; 151(1):449-57. PubMed ID: 7686944 [TBL] [Abstract][Full Text] [Related]
3. Neutralization of HIV-1 by anti-idiotypes to monoclonal anti-CD4. Potential for idiotype immunization against HIV. Sutor GC; Dreikhausen U; Vähning U; Jurkiewicz E; Hunsmann G; Lundin K; Schedel I J Immunol; 1992 Aug; 149(4):1452-61. PubMed ID: 1500724 [TBL] [Abstract][Full Text] [Related]
4. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells. Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249 [TBL] [Abstract][Full Text] [Related]
5. Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice. Boudet F; Theze J; Zouali M Virology; 1994 Apr; 200(1):176-88. PubMed ID: 7510435 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of murine monoclonal anti-CD4. Epitope recognition, idiotype expression, and variable region gene sequence. Lohman KL; Attanasio R; Buck D; Carrillo MA; Allan JS; Kennedy RC J Immunol; 1992 Nov; 149(10):3247-53. PubMed ID: 1385519 [TBL] [Abstract][Full Text] [Related]
7. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site. Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803 [TBL] [Abstract][Full Text] [Related]
8. Two new human monoclonal antibodies against HIV type 1 glycoprotein 120: characterization and neutralizing activities against HIV type 1 strains. Février M; Boudet F; Deslandres A; Theze J AIDS Res Hum Retroviruses; 1995 Apr; 11(4):491-500. PubMed ID: 7543271 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits. Fung MS; Sun CR; Liou RS; Gordon W; Chang NT; Chang TW; Sun NC J Immunol; 1990 Oct; 145(7):2199-206. PubMed ID: 2398276 [TBL] [Abstract][Full Text] [Related]
10. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Bower JF; Green TD; Ross TM Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the cross-reactive anti-gp120 antibody population in human immunodeficiency virus-infected asymptomatic individuals. Hariharan K; Nara PL; Caralli VM; Norton FL; Haigwood N; Kang CY J Virol; 1993 Feb; 67(2):953-60. PubMed ID: 7678311 [TBL] [Abstract][Full Text] [Related]
12. Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120. Connelly RJ; Kahn M; Blake J; Haffar OK; Thomas EK Virology; 1994 Dec; 205(2):554-7. PubMed ID: 7526543 [TBL] [Abstract][Full Text] [Related]
13. Temporal development and prognostic value of antibody response to the major neutralizing epitopes of gp120 during HIV-1 infection. Turbica I; Simon F; Besnier JM; LeJeune B; Choutet P; Goudeau A; Barin F J Med Virol; 1997 Jul; 52(3):309-15. PubMed ID: 9210041 [TBL] [Abstract][Full Text] [Related]
14. Generation and specificity of monoclonal anti-idiotypic antibodies against human HIV-specific antibodies. I. Cross-reacting idiotopes are expressed in subpopulations of HIV-infected individuals. Müller S; Wang HT; Kaveri SV; Chattopadhyay S; Köhler H J Immunol; 1991 Aug; 147(3):933-41. PubMed ID: 1861082 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration. D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019 [TBL] [Abstract][Full Text] [Related]
16. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein. Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203 [TBL] [Abstract][Full Text] [Related]
17. Importance of conformation on the neutralizing antibody response to HIV-1 gp120. Steimer KS; Haigwood NL Biotechnol Ther; 1991; 2(1-2):63-89. PubMed ID: 1726963 [TBL] [Abstract][Full Text] [Related]
18. Anti-idiotypic antibody response to monoclonal anti-CD4 preparations in nonhuman primate species. Attanasio R; Allan JS; Anderson SA; Chanh TC; Kennedy RC J Immunol; 1991 Jan; 146(2):507-14. PubMed ID: 1702802 [TBL] [Abstract][Full Text] [Related]
19. A highly selected panel of anti-CD4 antibodies fails to induce anti-idiotypic antisera mediating human immunodeficiency virus neutralization. Healey DG; Dianda L; Buck D; Schroeder K; Truneh A; Sattentau QJ; Beverley PC Eur J Immunol; 1991 Jun; 21(6):1491-8. PubMed ID: 1710569 [TBL] [Abstract][Full Text] [Related]